본문 바로가기
KERD
논문KCI 등재

Validity of Diagnostic Codes for Identification of Psoriasis Patients in Korea

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류피부과학

초록

Background: Recently, the number of nationwide medical researches on psoriasis using the National Health Insurance Service database has been on the rise. However, identification of psoriasis using diagnostic codes alone can lead to misclassification. Accuracy of the diagnostic codes and their concordance with medical records should be validated first to identify psoriasis patients correctly. Objective: To validate the diagnostic codes of psoriasis (International Classification of Diseases, 10th Revision L40) and to find the algorithm for the identification of psoriasis. Methods: We collected medical records of patients who received their first diagnostic codes of psoriasis during 5 years from five hospitals. Fifteen percent of psoriasis patients were randomly selected from each hospital. We performed a validation by reviewing medical records and compared 5 algorithms to identify the best algorithm. Results: Total of 538 cases were reviewed and classified as psoriasis (n=368), not psoriasis (n=159), and questionable (n=11). The most accurate algorithm was including patients with ≥1 visits with psoriasis as primary diagnostic codes and prescription of vitamin D derivatives. Its positive predictive value was 96.5% (95% confidence interval [CI], 93.9%~98.1%), which was significantly higher than those of the algorithm, including patients with ≥1 visits with psoriasis as primary diagnostic codes or including ≥1 visits with diagnostic codes of psoriasis (primary or additional) (91.0% and 69.8%). Sensitivity was 90.8% (95% CI, 87.2%~ 93.4%) and specificity was 92.5% (95% CI, 86.9%~ 95.9%). Conclusion: Our study demonstrates a validated algorithm to identify psoriasis, which will be useful for the nationwide population-based study of psoriasis in Korea.

Abstract

Background: Recently, the number of nationwide medical researches on psoriasis using the National Health Insurance Service database has been on the rise. However, identification of psoriasis using diagnostic codes alone can lead to misclassification. Accuracy of the diagnostic codes and their concordance with medical records should be validated first to identify psoriasis patients correctly. Objective: To validate the diagnostic codes of psoriasis (International Classification of Diseases, 10th Revision L40) and to find the algorithm for the identification of psoriasis. Methods: We collected medical records of patients who received their first diagnostic codes of psoriasis during 5 years from five hospitals. Fifteen percent of psoriasis patients were randomly selected from each hospital. We performed a validation by reviewing medical records and compared 5 algorithms to identify the best algorithm. Results: Total of 538 cases were reviewed and classified as psoriasis (n=368), not psoriasis (n=159), and questionable (n=11). The most accurate algorithm was including patients with ≥1 visits with psoriasis as primary diagnostic codes and prescription of vitamin D derivatives. Its positive predictive value was 96.5% (95% confidence interval [CI], 93.9%~98.1%), which was significantly higher than those of the algorithm, including patients with ≥1 visits with psoriasis as primary diagnostic codes or including ≥1 visits with diagnostic codes of psoriasis (primary or additional) (91.0% and 69.8%). Sensitivity was 90.8% (95% CI, 87.2%~ 93.4%) and specificity was 92.5% (95% CI, 86.9%~ 95.9%). Conclusion: Our study demonstrates a validated algorithm to identify psoriasis, which will be useful for the nationwide population-based study of psoriasis in Korea.

참고문헌 (22)

  1. Parisi R, "Global epidemiology of psoriasis: a systematic review of incidence and prevalence", J Invest Dermatol, 133, pp.377~385 (2013)
  2. Wilchesky M, "Validation of diagnostic codes within medical services claims", J Clin Epidemiol, 57, pp.131~141 (2004)
  3. Kim ES, "Impact of metabolic status on the incidence of psoriasis : a Korean nationwide cohort study", Sci Rep, 7, pp.1989~ (2017)
  4. Han JH, "Epidemiology and medication trends in patients with psoriasis : a nationwide population-based cohort study from Korea", Acta Derm Venereol, 98, pp.396~400 (2018)
  5. 이진용, "Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database", Annals of Dermatology, 29(6), pp.761~767 (2017), 대한피부과학회
  6. Improvement plan for validity of health insurance disease code and establishment of data application plan, "Park BJ", Health Insurance Review Agency Research Service, ~ (2003)
  7. Lee MS, "All-cause and cause-specific mortality in patients with psoriasis in Taiwan : a nationwide population-based study", J Invest Dermatol, 137, pp.1468~1473 (2017)
  8. Löfvendahl S, "Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study", PLoS One, 9, pp.e98024~ (2014)
  9. Ahlehoff O, "Psoriasis and risk of atrial fibrillation and ischaemic stroke : a Danish nationwide cohort study", Eur Heart J, 33, pp.2054~2064 (2012)
  10. Trevethan R, "Sensitivity, specificity, and predictive values:foundations, pliabilities, and pitfalls in research and practice", Front Public Health, 5, pp.307~ (2017)
  11. Parikh R, "Understanding and using sensitivity, specificity and predictive values", Indian J Ophthalmol, 56, pp.45~50 (2008)
  12. Hawass NE, "Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients", Br J Radiol, 70, pp.360~366 (1997)
  13. Raghupathi W, "Big data analytics in healthcare : promise and potential", Health Inf Sci Syst, 2, pp.3~ (2014)
  14. 김지애, "Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data", Journal of Korean Medical Science, 32(5), pp.718~728 (2017), 대한의학회
  15. Kim L, "A guide for the utilization of Health Insurance Review and Assessment service national patient samples", Epidemiol Health, 36, pp.e2014008~ (2014)
  16. Cheol Seong S, "Data resource profile : the national health information database of the National Health Insurance Service in South Korea", Int J Epidemiol, 46, pp.799~800 (2017)
  17. Huerta C, "Incidence and risk factors for psoriasis in the general population", Arch Dermatol, 143, pp.1559~1565 (2007)
  18. Seminara NM, "Validity of The Health Improvement Network(THIN)for the study of psoriasis", Br J Dermatol, 164, pp.602~609 (2011)
  19. Icen M, "Potential misclassification of patients with psoriasis in electronic databases", J Am Acad Dermatol, 59, pp.981~985 (2008)
  20. Asgari MM, "Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009", Pharmacoepidemiol Drug Saf, 22, pp.842~849 (2013)
  21. Oh EH, "Epidemiology and cardiovascular comorbidities in patients with psoriasis : a Korean nationwide population-based cohort study", J Dermatol, 44, pp.621~629 (2017)
  22. Ahlehoff O, "Psoriasis is associated with clinically significant cardiovascular risk : a Danish nationwide cohort study", J Intern Med, 270, pp.147~157 (2011)

관련 논문AI추천

Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database강성찬, 박종서, 이진용, 조성진대한피부과학회 · Annals of Dermatology2017 · 제29권 제6호The Clinical Profile of Patients with Psoriasis in Korea: A Nationwide Cross-Sectional Study (EPI-PSODE)김광중, 김기호, 김낙인, 김명화, 김병수, 김영도, 김태윤, 노영석, 박준수, 박철종, 서성준, 송해준, 신봉석, 안성구, 원영호, 유대영, 윤상웅, 윤석권, 윤재일, 이민걸, 이석종, 이주흥, 이지연, 장민수, 전지현, 조재위, 최용범, 최지호대한피부과학회 · Annals of Dermatology2017 · 제29권 제4호Prevalence of Vitiligo and Associated Comorbidities in Korea강희영, 김경완, 김기호, 김동현, 김태흥, 박철종, 신정현, 오상호, 이동윤, 이무형, 이상훈, 이승철, 이애영, 이혜민, 이희정, 최광성, 한승경연세대학교의과대학 · Yonsei Medical Journal2015 · 제56권 제3호건강보험심사평가원 표본자료를 이용한 국내 건선 환자의 항우울제 처방양상분석이의경, 한미연한국보건의료기술평가학회 · 보건의료기술평가2022 · 제10권 제2호Available Alternative Biologics and Disease Groups Influence Biologic Drug Survival in Patients with Psoriasis and Psoriatic Arthritis오소희, 윤현선, 최성준대한피부과학회 · Annals of Dermatology2022 · 제34권 제5호Defining the Relationship between Daily Exposure to Particulate Matter and Hospital Visits by Psoriasis Patients김상현, 김준영, 도영해, 류대식, 박경덕, 이석종, 이원주, 이은혜, 장용현대한피부과학회 · Annals of Dermatology2022 · 제34권 제1호

이 간행물의 다른 논문 (16건)